Cancer drugs
Decoupling market incumbency from organizational experience : a study of biotechnology's impact on the market for anti-cancer drugs
160
in vivo analysis of Drosophila deoxyribonucleoside kinase function in cell cycle, cell survival and anti-cancer drugs resistance.
41
Ferrocifen type anti cancer drugs
39
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms−
23
Applying System-Theoretic Accident Model Process view to patient safety for treatment with oral chemotherapy and anti-cancer drugs
65
Screening anti-colorectal cancer drugs: free radical chemotherapy
14
Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression data
18
The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project Rationale and design of the database and the collection of evidence available at approval of novel drugs
14
A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell–scaffold interaction and chemotherapeutic resistance of anticancer drugs
9
Intradermal Tests With Drugs: An Approach to Standardization
9
Mucins and tumor resistance to chemotherapeutic drugs
33
Biosynthetic engineering for the assembly of better drugs
211
Delivery of drugs and biomolecules using carbon nanotubes
22
Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs.
16
New inhibitors of quinolinate synthase as potential antibacterial drugs
286
Making rareness count: testing and pricing orphan drugs
18
Synapto-protective drugs evaluation in reconstructed neuronal network
10
Insiders, smart drugs et pharmaceuticalisation : éléments pour une typologie de la nouvelle déviance conformiste
23
Access to antiretroviral drugs and AIDS management in Senegal
10
Polymeric micelles as versatile carriers for drugs and nucleic acids
283